Ketim Technologies is redefining maternal mental health care with the first blood-based, predictive diagnostic for postpartum depression (PPD). Unlike current screening tools that rely on subjective questionnaires after symptoms appear, Ketim’s patented biomarker panel and AI-powered interpretation software identify risk months before onset with 94% accuracy.